The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 457.58M | 459.79M | 495.46M | 499.75M | 473.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 457.58M | 459.79M | 495.46M | 499.75M | 473.21M |
| Cost of Revenue | 267.26M | 268.56M | 264.55M | 266.84M | 257.04M |
| Gross Profit | 190.31M | 191.23M | 230.92M | 232.92M | 216.17M |
| SG&A Expenses | 85.95M | 86.36M | 75.91M | 76.56M | 70.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.21M | -3.23M | 5.73M | 5.78M | 1.03M |
| Total Operating Expenses | 380.86M | 382.70M | 377.03M | 380.30M | 357.73M |
| Operating Income | 76.72M | 77.09M | 118.43M | 119.45M | 115.47M |
| Income Before Tax | 96.42M | 96.89M | 131.31M | 132.44M | 119.94M |
| Income Tax Expenses | 15.32M | 15.39M | 28.36M | 28.60M | 21.84M |
| Earnings from Continuing Operations | 81.10M | 81.50M | 102.95M | 103.84M | 98.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 102.50K | 103.00K | 28.20K | 28.50K | 17.20K |
| Net Income | 81.21M | 81.60M | 102.98M | 103.87M | 98.12M |
| EBIT | 76.72M | 77.09M | 118.43M | 119.45M | 115.47M |
| EBITDA | 96.50M | 96.96M | 138.94M | 140.14M | 132.13M |
| EPS Basic | 0.04 | 0.04 | 0.06 | 0.06 | 0.05 |
| Normalized Basic EPS | 0.03 | 0.03 | 0.05 | 0.05 | 0.04 |
| EPS Diluted | 0.04 | 0.04 | 0.06 | 0.06 | 0.05 |
| Normalized Diluted EPS | 0.03 | 0.03 | 0.05 | 0.05 | 0.04 |
| Average Basic Shares Outstanding | 1.82B | 1.82B | 1.82B | 1.82B | 1.82B |
| Average Diluted Shares Outstanding | 1.82B | 1.82B | 1.82B | 1.82B | 1.82B |
| Dividend Per Share | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
| Payout Ratio | 68.43% | 68.43% | -- | -- | 33.34% |